Cheshire, Connecticut, United States Alexion Pharmaceuticals is the famous Corporate Investor, which was founded in 1992. The venture was found in North America in United States. The main office of represented Corporate Investor is situated in the Cheshire.
The standard case for the fund is to invest in rounds with 3-4 partakers. Despite the Alexion Pharmaceuticals, startups are often financed by Flagship Pioneering, DARPA. The meaningful sponsors for the fund in investment in the same round are Wellington Management, Viking Global Investors, RA Capital Management. In the next rounds fund is usually obtained by AstraZeneca, Wellington Management, Viking Global Investors.
Among the most popular portfolio startups of the fund, we may highlight Moderna Therapeutics. Among the most successful fund investment fields, there are Medical, Pharmaceutical. Moreover, a startup needs to be at the age of 4-5 years to get the investment from the fund. For fund there is a match between the country of its foundation and the country of its the most frequent investments - United States.
The increased amount of exits for fund were in 2018. The top activity for fund was in 2014. The usual things for fund are deals in the range of more than 100 millions dollars. The fund is constantly included in less than 2 investment rounds annually. When the investment is from Alexion Pharmaceuticals the average startup value is more than 1 billion dollars.
This organization was formed by Stephen Squinto.
Related Funds
| Fund Name | Location |
| Cascadia Partners | Oregon, Portland, United States |
| Delta Drone | Auvergne-Rhône-Alpes, France, Rhone-Alpes |
| DPR Construction | California, Redwood City, United States |
| Enterprise Community Investment | Columbia, Maryland, United States |
| Foundation Ventures | Al Qahirah, Cairo, Egypt |
| Greencoat Capital | England, London, United Kingdom |
| Honda Xcelerator | California, Mountain View, United States |
| K3 Ventures | Central Region, Singapore, Singapore |
| Kun Lun Stone Capital | China, Guangdong, Shenzhen |
| Lamphere Capital | New York, New York, United States |
| NantWorks | California, Culver City, United States |
| NexGen Energy | British Columbia, Canada, Vancouver |
| NUS Technology Holdings | Central, Central Region, Singapore |
| Stride.VC | England, London, United Kingdom |
| Swastika | China, Hong Kong, Hong Kong Island |
| Tata Opportunities Fund (TOF) | India, Maharashtra, Mumbai |
| Vireo Ventures | Berlin, Berlin, Germany |
| Vivo Capital | California, Palo Alto, United States |
| Weiss, Peck & Greer Venture Partners | - |
| Ziff Brothers Investments | New York, New York, United States |
1. You post comments at your own choice and risk. You bear the whole responsibility,related to their substance, content and the fact of publication. We shall not bear anyliability in respect of such comments.
2. While commenting, you shall use only actual, truthful and confirmed data. In thesame time you shall not use vulgar, abusive or defamatory language as well as expresshatred or call to violence or cruelty.
3. We do not intend to delete any comments on the website unless within our “noticeand take down” procedure.
4. We can moderate comments at any time.
5. While commenting, you are under the rule of our website’s terms of use and privacypolicy.
6. We retain our right to delete any comment or any other content of the website at ourwill in case we know or suppose such content is illegal or breaches any lawful right.
Review
- No reviews are submitted yet.
Sign up and get access to full fund profile and advanced analysis.
Full teamIndustries heatmapStages heatmapGeorgaphy breakdownCoinvestorsPortfolio analysisPerformance indexesLatest highlights
Unlock all data 